References
Sanyal AJ (2019) Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 16:377–386. https://doi.org/10.1038/S41575-019-0144-8
Petta S, Marrone O, Torres D et al (2015) Obstructive sleep apnea is associated with liver damage and atherosclerosis in patients with non-alcoholic fatty liver disease. PLoS One. https://doi.org/10.1371/JOURNAL.PONE.0142210
Wong RJ, Singal AK (2020) Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014–2019. JAMA Netw Open. https://doi.org/10.1001/JAMANETWORKOPEN.2019.20294
Diehl AM, Day C (2017) Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med 377:2063–2072. https://doi.org/10.1056/NEJMRA1503519
Saitta C, Caruso A, Maimone S et al (2022) Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity. Intern Emerg Med. https://doi.org/10.1007/S11739-022-02971-5
Raimondo G, Saitta C, Lombardo D et al (2020) Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy. Liver Int 40:1601–1609. https://doi.org/10.1111/LIV.14473
Bechmann LP, Hannivoort RA, Gerken G et al (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56:952–964. https://doi.org/10.1016/J.JHEP.2011.08.025
Peiseler M, Schwabe R, Hampe J et al (2022) Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. J Hepatol. https://doi.org/10.1016/J.JHEP.2022.06.012
Raimondo G, Locarnini S, Pollicino T et al (2019) Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol 71:397–408. https://doi.org/10.1016/J.JHEP.2019.03.034
Mulrooney-Cousins PM, Michalak TI (2007) Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol 13:5682–5686. https://doi.org/10.3748/WJG.V13.I43.5682
Raimondo G, Pollicino T, Squadrito G (2005) What is the clinical impact of occult hepatitis B virus infection? Lancet 365:638–640. https://doi.org/10.1016/S0140-6736(05)17961-6
Alon L, Corica B, Raparelli V et al (2022) Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Prev Cardiol 29:938–946. https://doi.org/10.1093/EURJPC/ZWAB212
Pothineni NVK, Subramany S, Kuriakose K et al (2017) Infections, atherosclerosis, and coronary heart disease. Eur Heart J 38:3195–3201. https://doi.org/10.1093/EURHEARTJ/EHX362
Cangemi R, Pignatelli P, Carnevale R et al (2016) Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia. J Infect 73:107–114. https://doi.org/10.1016/J.JINF.2016.05.013
Carnevale R, Sciarretta S, Valenti V et al (2020) Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. Eur Heart J 41:3156–3165. https://doi.org/10.1093/EURHEARTJ/EHZ893
Wang CR, Tsai HW (2021) Human hepatitis viruses-associated cutaneous and systemic vasculitis. World J Gastroenterol 27:19–36. https://doi.org/10.3748/WJG.V27.I1.19
Cacoub P, Terrier B (2009) Hepatitis B-related autoimmune manifestations. Rheum Dis Clin North Am 35:125–137. https://doi.org/10.1016/J.RDC.2009.03.006
Mason A, Theal J, Bain V et al (2005) Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am J Gastroenterol 100:972–976. https://doi.org/10.1111/J.1572-0241.2005.41308.X
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors state that they have no conflict of interests..
Human and animal rights
This article does not contain any studies directly involving human participants or animals.
Informed consent
For this type of study, formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cangemi, R., Miglionico, M. & Basili, S. Infections as predictors of NAFLD progression. Intern Emerg Med 17, 2185–2186 (2022). https://doi.org/10.1007/s11739-022-03096-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-022-03096-5